Trop-2 mRNA expression and association with clinical outcomes with sacituzumab govitecan (SG) in patients with HR+/HER2- metastatic breast cancer (mBC): Biomarker results from the phase 3 TROPiCS-02 study.
Sacituzumab Govitecan
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Trop-2 mRNA expression and association with clinical outcomes with sacituzumab govitecan (SG) in patients with HR+/HER2- metastatic breast cancer (mBC): Biomarker results from the phase 3 TROPiCS-02 study. ### Output: Sacituzumab Govitecan